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Dr J. Hammon (Winston-Salem, NC): I congratulate Dr Boodhwani
and his coworkers on an excellent randomized prospective study,
and thanks again for sending me the article and the slides in
advance. Our group and others have admired the work of Dr
Nathan and people like yourself who have done careful random-
ized studies evaluating hypothermia as a neuroprotective adjunct
to surgery. The previous article that you referred to was what I
would call a landmark study in that as a result of your publication,
many groups, including ours, stopped doing active rewarming in
the operating room, and I noticed you say in your article that this
work served to validate that study.
In terms of the hypothesis that you gave at the beginning of
your presentation, you stated that you wanted to validate the study
and to actually examine the effects of hypothermia without the
effects of rewarming. Tell me how you arrived at this and why you
used the water jacket on the hypothermic patients, given that the
pump temperature was exactly the same as the temperature that
you were aiming for (34.5°C) and should have maintained the
brain at that temperature?
Dr Boodhwani: Thank you for your positive comments. First
of all, the reason for the confirmatory study was the fact that the
first study was confounded by the effect of rewarming. Although
hyperthermia was avoided in both studies, it was impossible in the
first study to separate the potential harmful effect of rewarming in
the normothermic group from the potential beneficial effect of
hypothermia in the hypothermic group, and therefore we wanted to
conduct a study in which pure hypothermia was the only interven-
tion. The best way to achieve that without relying on the CPB
machine, for which you would have to first cannulate the aorta and
venous system and then go on-pump and reduce the temperature,
we chose to use an external method of reducing the temperature, so
that by the time any possible emboli could occur to the cerebral
vasculature, our intervention was already in place, which was what
we demonstrated in this study.
Dr Hammon: I think it was admirable for you to show that an
operation like this can be carried out with a 3-month neurocogni-
tive deficit rate of less than 10%, which mirrors some of our own
studies. I think that should be the standard that all of us aspire to.
I would have to say that when you reduce neurocognitive
dysfunction rates to that level, determining a statistically signifi-
cant difference between 2 groups becomes difficult, even with your
40% rate at the end of discharge, when most of the older rates were
in the 60% to 70% range. When we calculate the statistical power
with our techniques, at least 400 patients would be required to
be able to tell a difference if you had a deficit rate of 40% at
discharge. Did you do a statistical power calculation?
Dr Boodhwani: Absolutely. This was reported in our article as
well. The study was powered to detect a 25% reduction in cogni-
tive deficits with the intervention, and that gave us a sample size
of 300, and you will note that the study was stopped at 267 because
of various logistic and funding issues. However, having done that
prospectively, perhaps what is even more important is that at the
time of discharge, the actual difference between the groups is only
4%. Although we were powered to detect a significant difference,
the actual treatment effect is quite low.
Dr Hammon: I think it is very important for you to show that
last slide and to emphasize in the article that what most of us think
is the real problem in terms of reducing temperature in patients
would be active rewarming. For many perfusionists around the
country, and if you look at the AmSECT meetings that I go to
regularly, the standard procedure 10 years ago was to cool the
patient to 28°C and then rewarm the patient to 37°C in approxi-
mately 10 or 15 minutes, which means the water bath on the pump
has to be set to 38.5°C, and therein I think lies the rub; that is
where the injury occurs and has been shown in animal experi-
ments. So I think yours is a very valuable contribution. I think you
have to say that hypothermia is very important for our patients; I
don’t think we can downgrade that, but active rewarming is very
dangerous. Thank you.
Dr Boodhwani: Thank you, Dr Hammon. I would just like to
echo those comments. One of the things that this study reempha-
sizes is that surgeons do need to pay attention to the way in which
temperature is managed, and in particular avoid rewarming. One
caveat, however, is that the study was not powered to demonstrate
an effect of hypothermia on strokes. Certainly, you would need a
study with thousands of patients to demonstrate that, and we can’t
exclude a beneficial effect of hypothermia in the setting where
there is a high suspicion for clinical stroke. However, with respect
to cognitive deficits, certainly our studies combined demonstrate
that rewarming is harmful and that hypothermia in and of itself
does not confer a significant benefit.
Dr G. Parr (Morristown, NJ): I congratulate the authors on a
well-designed and carried-out study. In your conclusions you note
that the major problem may be the underlying cerebrovascular
disease. If that were the case, you should note, as others have, that
neurocognitive dysfunction is much more prevalent in the elderly
patients, that is, you should have a correlation of age with neuro-
cognitive dysfunction after 3 months. Did you note this in your
patients?
Dr Boodhwani: That is correct. That is exactly what we noted,
and actually we published this in Circulation in 2006 (Circulation
2006;114:I461-6) looking at predictors of neurocognitive deficits
in a large cohort of patients, close to 500. We found that age was
extremely predictive of neurocognitive deficits, and that the serum
creatinine level, which likely represents an overall premorbid state,
was also predictive of neurocognitive deficits.
Dr Parr: Secondarily, you excluded cerebral hypoperfusion,
but you really don’t have any data in this study on cerebral
hypoperfusion.
Dr Boodhwani: Cerebral hypoperfusion is a hypothesis that
has been maintained in the literature as a source of cognitive
deficits. Our goal here was primarily based on the theory that
POCDs occur from an ischemic/embolic cause. Certainly we took
care to ensure that the blood pressure maintained during CPB was
similar between groups and maintained as per guidelines, but we
didn’t specifically control for that.
Dr R. Griepp (New York, NY): Just a follow-up question on
that. You state that your pressures were the same. So were the
flows the same, your CPB flows? I found it sort of interesting that
you had exactly the same number of emboli in the hypothermic
and normothermic groups. One would assume that that meant your
flows were the same. Were they?
Dr Boodhwani: Yes, the flows were the same and maintained
within a predefined interval throughout the study.
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Dr Griepp: The pressure and the flows were the same both in
the 34°C and in the 37°C groups?
Dr Boodhwani: That is correct.
Dr Griepp: That is unusual.
Dr Boodhwani: I would like to add that the hypothermic
patients required more phenylephrine to maintain blood pressure.
Dr H. Nathan (Ottawa, ON Canada): I thank the Society for the
opportunity to present our results. I would like to take the liberty of
interpreting the clinical relevance of our findings in the context of our
research and the research of others. Our study and the work of Van
Dijk and colleagues (JAMA. 2002;287:1405-12), comparing patients
undergoing surgery with and without CPB, indicate that CPB is
unlikely an important cause of cognitive deficits when conducted with
the best possible technology and appropriate temperature manage-
ment. The lack of effect of mild hypothermia in reducing the inci-
dence of cognitive deficits suggests to us that the cause of these
deficits is not ischemic. Mild hypothermia has, however, been shown
to reduce ischemic brain injury in the laboratory and in patients with
out-of-hospital cardiac arrest. It is possible, but not proven, that mild
hypothermia may benefit patients at risk of cerebral ischemia in the
operating room. I suggest that the 2 limbs of this trial offer useful
management strategies. Patients at high risk of cerebrovascular events
and those with carotid disease, high creatinine levels, or a previous
stroke could be maintained at 34°C throughout the procedure, first
using cooling pads at the beginning, a constant temperature on bypass,
and then they could be rewarmed postbypass in the ICU. This strategy
may provide neuroprotection to these patients without increasing
operating room time by attempting to rewarm on CPB. We have
shown that it is safe to take most patients to 34°C. On the other hand,
if the patient is not at high risk of cerebrovascular injury, one could
maintain the temperature at approximately 36°C to 37°C throughout
the case, again avoiding rewarming on CPB and providing some of
the benefits of normothermia.
I concur with Dr Hammon that it is important to avoid rewarm-
ing on CPB, which even when done cautiously, as in our first
study, seems to be related to cerebral injury.
Dr P. Kurlansky (Miami, Fla): Given that rewarming is ap-
parently damaging, I was wondering if you had any idea as to the
basic science mechanism, if it has to do with the solubility of gas
at different temperatures and coming out of solution? What is the
exact problem?
Do you have any advice for those situations, deep hypothermia
for aortic surgery, in which rewarming is unavoidable? Is there any
technique of rewarming that might be more protective against the
cerebral injury that you have found?
Dr Boodhwani: From a basic science point of view, a number
of different mechanisms have been implicated in the beneficial
effects of hypothermia and detrimental effects of rewarming, and
they range anywhere from the onset of cerebral injury to excitatory
transmitter release, all the way down to the cellular events leading
to neuronal death, and any of those mechanisms might be at play.
Certainly I think intuitively it makes sense to extend the period of
rewarming over a longer period of time and to minimize the rate of
increase in temperature over a short period of time in an effort to
avoid reperfusion injury.
Dr C. Feindel (Toronto, Ontario, Canada): That was an ex-
cellent presentation. Just for interest’s sake, can we just have a
quick show of hands to see who uses standard rewarming tech-
niques? (Show of hands.) And those who use this modified tech-
nique? The minority it seems. Thank you.
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